ASTRO Annual Meeting

Healio.com brings you the highlights from the American Society for Radiation Oncology Annual Meeting. Refer back to this page often to read the latest news from ASTRO, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News CoveragePerspective

Ibrutinib extends PFS in relapsed, refractory mantle cell lymphoma

December 17, 2015
ORLANDO, Fla. — Treatment with ibrutinib prolonged PFS and led to a significantly higher overall response rate compared with temsirolimus in…
Meeting News CoveragePerspective

Matched-sibling HSCT often successful for patients with sickle cell disease

December 16, 2015
ORLANDO, Fla. — Hematopoietic stem cell transplantation from human leukocyte antigen-matched siblings was successful among more than 90% of…
Meeting News CoveragePerspective

Ibrutinib, rituximab appear safe, effective for treatment-naive follicular lymphoma

December 16, 2015
ORLANDO, Fla. — Combined treatment with ibrutinib and rituximab demonstrated robust clinical activity and produced a high overall response rate…
Meeting News CoveragePerspective

Eltrombopag improves platelet counts, reduces fatigue for some patients with severe thrombocytopenia

December 16, 2015
ORLANDO, Fla. — Eltrombopag improved platelet counts and alleviated fatigue among low-risk patients with myelodysplastic syndromes who…
Meeting News Coverage

Higher-volume facilities associated with improved survival for NHL

December 8, 2015
ORLANDO, Fla. — Patients with non-Hodgkin’s lymphoma who are treated at facilities with a high volume of similar patients experienced…
Meeting News CoveragePerspective

Hemoglobin modifier appears safe, effective for sickle cell disease

December 8, 2015
ORLANDO, Fla. — GBT440, a novel small molecule hemoglobin modifier, reduced hemolysis and improved anemia without causing tissue hypoxia among…
Meeting News CoveragePerspective

Recombinant Factor VIII products increase inhibitor development in severe hemophilia A

December 8, 2015
ORLANDO, Fla. — Recombinant Factor VIII replacement products for severe hemophilia A appeared to increase inhibitor development 1.87-fold…
Meeting News Coverage

Novel treatment provides less toxic approach for pediatric HLH management

December 8, 2015
ORLANDO, Fla. — NI-0501 demonstrated safety and efficacy for the treatment of pediatric patients with hemophagocytic lymphohistiocytosis who…
Meeting News CoveragePerspective

High-dose melphalan plus HSCT extends PFS, OS in newly diagnosed multiple myeloma

December 8, 2015
ORLANDO, Fla. — High-dose melphalan with autologous hematopoietic stem cell transplantation significantly prolonged PFS and OS compared with…
Meeting News CoveragePerspective

Despite advances in triplets, HSCT continues to confer benefit in multiple myeloma

December 7, 2015
ORLANDO, Fla. — Autologous hematopoietic stem cell transplantation should remain a standard of care for younger patients with de novo multiple…